Lv1
100 积分 2023-05-31 加入
FDA Drug Approval Summary: Bevacizumab (Avastin®) Plus Carboplatin and Paclitaxel as First-Line Treatment of Advanced/Metastatic Recurrent Nonsquamous Non-Small Cell Lung Cancer
2个月前
已完结
AIM2 and NLRC4-driven inflammasome activation in adult-onset Still’s disease and the preliminary therapeutic effect exploration of carboxyamidotriazole
9个月前
已完结
An effective LC–MS method for the simultaneous determination of a potential anti‐rheumatoid arthritis drug, carboxyamidotriazole, and its major metabolite in rat plasma
9个月前
已完结
Therapeutic Effect of Carboxyamidotriazole on Adjuvant Arthritis in Rats
9个月前
已完结
[Anti-inflammatory and analgesic potency of carboxyamidotriazole, a tumoristatic agent]
9个月前
已关闭
皖公网安备34019202002308
